SCHEMBL4907798

SCHEMBL4907798

FCc1ccccc1-c1nc2ccccc2s1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.58
NPC1 O15118 9/20 0.58
RAB9A P51151 9/20 0.58
ALDH1A1 P00352 7/20 0.58
MAPT P10636 5/20 0.58
SMN1; SMN2 Q16637 5/20 0.58
GAA P10253 5/20 0.58
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
L3MBTL1 Q9Y468 4/20 0.58
TDP1 Q9NUW8 3/20 0.58
NPSR1 Q6W5P4 1/20 0.50
POLB P06746 2/20 0.49
ILK Q13418 4/20 0.48
GLA P06280 3/20 0.48
HCRTR1 O43613 1/20 0.48
HSD17B10 Q99714 2/20 0.47
TP53 P04637 1/20 0.47
TSHR P16473 1/20 0.47
S1PR2 O95136 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21779833 0.83 KDM4E (0.63) KDM4ENPC1RAB9AALDH1A1MAPT
SCHEMBL21301181 0.83 KDM4E (0.58) KDM4ENPC1RAB9AALDH1A1MAPT
SCHEMBL900512 0.83 KDM4E (0.58) KDM4ENPC1RAB9AALDH1A1MAPT
SCHEMBL11489855 0.83 KDM4E (0.58) KDM4ENPC1RAB9AALDH1A1MAPT
SCHEMBL21699657 0.83 KDM4E (0.58) KDM4ENPC1RAB9AALDH1A1MAPT
SCHEMBL24182079 0.83 KDM4E (0.63) KDM4ENPC1RAB9AALDH1A1MAPT
SCHEMBL231307 0.82 KDM4E (0.75) KDM4ENPC1RAB9AALDH1A1MAPT
SCHEMBL21362250 0.81 KDM4E (0.59) KDM4ENPC1RAB9AALDH1A1MAPT
SCHEMBL8045063 0.81 KDM4E (0.55) KDM4ENPC1RAB9AALDH1A1MAPT
SCHEMBL12854008 0.80 KDM4E (0.72) KDM4ENPC1RAB9AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080299041-A1 HETEROCYCLIC INDENE DERIVATIVES AND THEIR RADIOISOTOPE LABELED COMPOUNDS FOR IMAGING BETA-AMYLOID DEPOSITION SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) 2008-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080299041-A1 HETEROCYCLIC INDENE DERIVATIVES AND THEIR RADIOISOTOPE LABELED COMPOUNDS FOR IMAGING BETA-AMYLOID DEPOSITION APP, BACE1, PSEN1 KDM4E 3533/4885NPC1 41/4885RAB9A 2635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.